-+ 0.00%
-+ 0.00%
-+ 0.00%

Correction : Canaccord Genuity Maintains Hold on Repligen, Lowers Price Target to $150 (Ticker changed)

Benzinga·04/17/2025 14:15:25
Listen to the news

Correction : Canaccord Genuity analyst Kyle Mikson maintains Repligen (NASDAQ:RGEN) with a Hold and lowers the price target from $170 to $150. (Ticker changed)